Contrast Sensitivity Outcomes in the ABC Trial: A Randomized Trial of Bevacizumab for Neovascular Age-Related Macular Degeneration
Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.10-6208
Full Text
Open PDFAbstract
Available in full text
Date
May 11, 2011
Authors
Publisher
Association for Research in Vision and Ophthalmology (ARVO)